Medical Marijuana (MMJ)

Germany’s Cannabis Act (CanG) is beginning to transform the country's medical cannabis market, with potential opportunities to expand telemedicine, improve physician training, and enhancing accessibility in this rapidly growing industry.

The patient-centered organization announced its 2025 plans for medical cannabis at the national level.

This month’s webinar covered recent studies on cannabis use during pregnancy, CBD and anxiety, cannabis tea, and more.

This month’s webinar covered research on cannabis studied as a treatment for rheumatic disorders, menstrual symptoms, eczema, and more.

MM411’s president and co-founder, Chris DeVol, discusses challenges and trends in global cannabis education, plus upcoming initiatives of the company.

MM411’s president and co-founder, Chris DeVol, discusses the evolution of the company, their most popular cannabis education courses, and their partnership with Cannabis Science and Technology.

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.

A ruling is expected this week regarding the lawsuit challenging the validity of signatures collected for two medical cannabis measures.

As discussions about the federal scheduling of cannabis continue, efforts by medical cannabis advocates are intensifying. One such advocate is Americans for Safe Access (ASA), a nonprofit organization founded by patients for patients. Since 2002, ASA has been championing the rights of medical cannabis patients and has recently launched new campaigns and strategies to refocus attention on patient needs. In this interview, Steph Sherer, founder and president of ASA, reflects on past successes in medical cannabis advocacy, shares her perspective on recent cannabis and hemp policymaking, and outlines the next steps for advancing a unified medical cannabis message on Capitol Hill—a message that could bring about the changes patients have long awaited.

This month’s Healer webinar provided a deep dive into several studies on cannabis for various conditions.

California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.

Americans for Safe Access, a medical cannabis patient advocacy organization, held a briefing on the final day of the comment period for the proposed rulemaking on cannabis.

The Senate’s latest attempt at legal medical cannabis access for patients was added to a bill on hemp regulations.

This month’s Healer webinar discussed several studies on cannabis and symptoms of dementia and cognitive decline.

Nebraska advocates are a few weeks away from knowing if two medical cannabis measures have enough signatures to qualify to appear on the 2024 ballot.

The new law eliminates the 37% excise tax for medical cannabis cardholders for certain products.

This webinar from MM411 explored the far-ranging studies of Dr. Raphael Mechoulam and Dr. Ethan Russo on the science and medicine of cannabis and other plants.

The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.

Kentucky Governor signs HB 829, and introduces lottery for dispensary applications.

As we celebrate the 4/20 holiday, here is a selection of medical cannabis coverage we have explored in the cannabis industry this year so far.

Keynote speaker Jamila Owens-Todd shares her perspectives on cannabis from medical and science viewpoints.

One step forward, two steps back: updates on cannabis legal movements in three different states.

After stalled attempts over the years, a bill that would create a medical cannabis program in the Sunflower State has made an appearance.

Clinically significant reductions in symptoms were reported.

Join us for the final installment of this multipart interview series as the co-founders of Cannabis Patients Pacific Northwest share how they envision the future of cannabis regulations.